1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression : a randomized placebo-controlled trial
- Contribution to journal › Article
-
Mark
Kynurenine pathway metabolites are increased in inflammatory depression and decrease with omega-3 treatment
- Contribution to journal › Article
-
Mark
Plasma proteomic profile of inflammatory depressive symptoms
- Contribution to journal › Article
- 2025
-
Mark
A plasma protein profile of antidepressant response to omega-3 fatty acids
- Contribution to journal › Article
-
Mark
Positive correlation between plasma and cerebrospinal fluid galectin-3 in suicide attempters
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid platelet-derived growth factor receptor-beta is negatively correlated with depressive symptom severity in suicide attempters
- Contribution to journal › Article
- 2024
-
Mark
Inflammatory depression is associated with selective glomerular hypofiltration
- Contribution to journal › Article
- 2023
-
Mark
An inflamed subtype of difficult-to-treat depression
- Contribution to journal › Article
-
Mark
Add-on pramipexole for anhedonic depression : study protocol for a randomised controlled trial and open-label follow-up in Lund, Sweden
- Contribution to journal › Article
- 2022
-
Mark
Preliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic Depression
- Contribution to journal › Article
